Here, only 19 percent had a preferred vaccine. That was before the AstraZeneca vaccine was approved for use in the EU, and it has a bearing on the fact that more people now prefer one vaccine over others.
This is the assessment of Camilla Foged, professor at the Department of Pharmacy at the University of Copenhagen.
– I think that a little over a month ago we only had two vaccines that seemed very similar. So therefore I can well understand that there were not many who had a preference there.
– In the meantime, we have received a third vaccine, which works a little differently. And there has been a lot of discussion about the new vaccine, which has a lesser effectiveness than the other two. So that’s really what I had imagined, says Camilla Foged.
However, she thinks that the discussion about the effectiveness of vaccines has received “a little too much focus”.
– Because it is not always completely clear to people what is actually meant by how effective the vaccine is. However, if you are in risk groups or belong to the oldest age groups, I think it is relevant to go up in the vaccine, but for other groups it does not matter much.
Even though almost everyone else has a vaccine preference, you do not get the opportunity to choose for yourself. This was confirmed by the health authorities as early as December.
But the measurement should not worry the authorities, assesses Camilla Foged.
– I do not think one should raise eyebrows if people agree to take the AstraZeneca vaccine. We have not seen the same in Denmark as in Germany, where people say no thanks to the vaccine from AstraZeneca, she says.
The AstraZeneca vaccine is only approved in Denmark for people under 65 years of age.
Of the 379 respondents who have a preferred vaccine, 87 percent answer that they prefer Pfizer’s coronavine vaccine. 8 percent prefer Modernas, while 3 percent prefer AstraZenecas.
46 percent of the population does not have a preference when it comes to a coronavina vaccine, while 12 percent respond “do not know”.
The Voxmeter survey was collected from February 23 to February 26 with responses from 1054 representative respondents. The survey is web-based among randomly selected.
The answers to vaccine preference come from the 890 people who answered yes to being vaccinated when offered a vaccine.